46 results on '"Tang, W.H. Wilson"'
Search Results
2. Defining Echocardiographic Degrees of Right Heart Size and Function in Pulmonary Vascular Disease From the PVDOMICS Study
3. The Gut Microbial Metabolite Trimethylamine N-oxide, Incident CKD, and Kidney Function Decline
4. Unraveling the Complex Relationship Between Gut Microbiome and Cardiovascular Diseases
5. Cardiac MRI-Enriched Phenomapping Classification and Differential Treatment Outcomes in Patients With Ischemic Cardiomyopathy
6. Hemodynamic Determinants of Cardiac Surgery-Associated Acute Kidney Injury
7. Worsening heart failure: a concept in evolution
8. Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial
9. Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression
10. Classification and Predictors of Right Ventricular Functional Recovery in Pulmonary Arterial Hypertension
11. Common Variants on FGD5 Increase Hazard of Mortality or Rehospitalization in Patients With Heart Failure From the ASCEND-HF Trial
12. Prognostic Power of Quantitative Assessment of Functional Mitral Regurgitation and Myocardial Scar Quantification by Cardiac Magnetic Resonance
13. Predictive Modeling to Assess Pretest Probability of Transthyretin Gene Variants Based on Demographic Information
14. Dysregulated amino acid metabolism in heart failure: role of gut microbiome
15. Hemodynamic Profiling and Prognosis in Cardiac Amyloidosis
16. Dietary Meat, Trimethylamine N-Oxide-Related Metabolites, and Incident Cardiovascular Disease Among Older Adults: The Cardiovascular Health Study
17. Decongestion With Acetazolamide in Acute Decompensated Heart Failure Across the Spectrum of Left Ventricular Ejection Fraction: A Prespecified Analysis From the ADVOR Trial
18. Targeted Inhibition of Gut Microbial TMAO Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease
19. Durable Mechanical Circulatory Support in Patients With Amyloid Cardiomyopathy: Insights From INTERMACS
20. Sodium-Glucose Cotransporter-2 Inhibitors and Loop Diuretics for Heart Failure: Priming the Natriuretic and Metabolic Reserve of the Kidney
21. Virtual Versus In-Person Visits and Appointment No-Show Rates in Heart Failure Care Transitions
22. Racial Differences in Diuretic Efficiency, Plasma Renin, and Rehospitalization in Subjects With Acute Heart Failure
23. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease
24. Renal Effects of Intensive Volume Removal in Heart Failure Patients With Preexisting Worsening Renal Function
25. Microbial Transplantation With Human Gut Commensals Containing CutC Is Sufficient to Transmit Enhanced Platelet Reactivity and Thrombosis Potential
26. Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling: A Cardiopulmonary Exercise Testing Imaging Evaluation
27. A common variant alters SCN5A–miR-24 interaction and associates with heart failure mortality
28. Abstract 21098: Variables From the CMS Heart Failure Readmission Model Poorly Predict 30-Day Rehospitalization Risk in Heart Failure Patients From a Large Academic Hospital System
29. Abstract 12243: A Contemporary Analysis of Predictors of Mortality in Patients With Heart Failure and Preserved Ejection Fraction From the National Inpatient Sample 2014 Database
30. Compensatory Distal Reabsorption Drives Diuretic Resistance in Human Heart Failure
31. Gut microbiome and its role in cardiovascular diseases
32. PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics
33. Report of the National Heart, Lung, and Blood Institute Working Group on the Role of Microbiota in Blood Pressure Regulation: Current Status and Future Directions
34. Gut Microbiota in Cardiovascular Health and Disease
35. Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function
36. Insufficient reduction in heart rate during hospitalization despite beta‐blocker treatment in acute decompensated heart failure: insights from the ASCEND‐HF trial
37. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
38. Terminology and definition of changes renal function in heart failure
39. Myeloperoxidase, paraoxonase-1, and HDL form a functional ternary complex
40. Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia
41. Detectable Subclinical Myocardial Necrosis Is Associated With Cardiovascular Risk in Stable Patients With Diabetes
42. Determinants of dynamic changes in serum creatinine in acute decompensated heart failure: the importance of blood pressure reduction during treatment
43. Troponin I in acute decompensated heart failure: insights from the ASCEND-HF study
44. Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure
45. Revisiting the cardio-renal hypothesis: the pivotal role of the kidney in congestive heart failure
46. Exploring new drugs for heart failure: the case of urocortin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.